REVVITY, INC Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
REVVITY, INC (RVTY) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.30% for the 12-month period ending 2025-12-28, per its 10-K filed 2026-02-24.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-02-24
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2021-04-04 was 0.20%, a 33.33% decline year-over-year.
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2020-04-05 was 0.30%, a 0.00% change year-over-year.
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2019-03-31 was 0.30%, a 25.00% decline year-over-year.
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2018-04-01 was 0.40%, a 20.00% decline year-over-year.
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.30%, a 0.00% change from fiscal 2024.
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.30%, a 50.00% increase from fiscal 2023.
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.20%, a 0.00% change from fiscal 2023.
- REVVITY, INC share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.20%, a 0.00% change from fiscal 2022.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-12-28 | 0.30% 10-K · filed 2026-02-24 | |||
| 2024-12-29 | 0.30% 10-K · filed 2026-02-24 | |||
| 2023-12-31 | 0.20% 10-K · filed 2026-02-24 | |||
| 2023-01-01 | 0.20% 10-K · filed 2025-02-25 | |||
| 2022-01-02 | 0.20% 10-K · filed 2024-02-27 | |||
| 2021-10-03 | 0.20% 10-Q · filed 2021-11-09 | |||
| 2021-07-04 | 0.20% 10-Q · filed 2021-08-10 | |||
| 2021-04-04 | 0.20% 10-Q · filed 2021-05-11 | |||
| 2021-01-03 | 0.30% 10-K · filed 2023-03-01 | |||
| 2020-10-04 | 0.30% 10-Q · filed 2021-11-09 | |||
| 2020-07-05 | 0.30% 10-Q · filed 2021-08-10 | |||
| 2020-04-05 | 0.30% 10-Q · filed 2021-05-11 | |||
| 2019-12-29 | 0.30% 10-K · filed 2022-03-03 | |||
| 2019-09-29 | 0.30% 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | 0.30% 10-Q · filed 2020-08-11 | |||
| 2019-03-31 | 0.30% 10-Q · filed 2020-05-12 | |||
| 2018-12-30 | 0.40% 10-K · filed 2021-03-02 | |||
| 2018-09-30 | 0.40% 10-Q · filed 2019-11-05 | |||
| 2018-07-01 | 0.40% 10-Q · filed 2019-08-06 | |||
| 2018-04-01 | 0.40% 10-Q · filed 2019-05-07 | |||
| 2017-12-31 | 0.40% 10-K · filed 2020-02-25 | |||
| 2017-10-01 | 0.40% 10-Q · filed 2018-11-06 | |||
| 2017-07-02 | 0.50% 10-Q · filed 2018-08-07 | |||
| 2017-04-02 | 0.50% 10-Q · filed 2018-05-08 | |||
| 2017-01-01 | 0.60% 10-K · filed 2019-02-26 | |||
| 2016-10-02 | 0.60% 10-Q · filed 2017-11-07 | |||
| 2016-07-03 | 0.60% 10-Q · filed 2017-08-08 | |||
| 2016-04-03 | 0.60% 10-Q · filed 2017-05-09 | |||
| 2016-01-03 | 0.60% 10-K · filed 2018-02-27 | |||
| 2015-10-04 | 0.60% 10-Q · filed 2016-11-08 | |||
| 2015-06-28 | 0.60% 10-Q · filed 2016-08-09 | |||
| 2015-03-29 | 0.60% 10-Q · filed 2016-05-10 | |||
| 2014-12-28 | 0.70% 10-K · filed 2017-02-28 | |||
| 2014-09-28 | 0.70% 10-Q · filed 2015-11-10 | |||
| 2014-06-29 | 0.70% 10-Q · filed 2015-08-04 | |||
| 2014-03-30 | 0.70% 10-Q · filed 2015-05-05 | |||
| 2013-12-29 | 0.80% 10-K · filed 2016-03-01 | |||
| 2013-09-29 | 0.80% 10-Q · filed 2014-11-04 | |||
| 2013-06-30 | 0.80% 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | 0.80% 10-Q · filed 2014-05-06 | |||
| 2012-12-30 | 1.20% 10-K · filed 2015-02-24 | |||
| 2012-09-30 | 1.20% 10-Q · filed 2013-11-05 | |||
| 2012-07-01 | 1.20% 10-Q · filed 2013-08-06 | |||
| 2012-04-01 | 1.20% 10-Q · filed 2013-05-06 | |||
| 2012-01-01 | 1.10% 10-K · filed 2014-02-25 | |||
| 2011-10-02 | 1.10% 10-Q · filed 2011-11-04 | 1.10% 10-Q · filed 2012-11-06 | ||
| 2011-07-03 | 1.10% 10-Q · filed 2011-08-10 | 1.10% 10-Q · filed 2012-08-07 | ||
| 2011-04-03 | 1.10% 10-Q · filed 2012-05-08 | |||
| 2011-01-02 | 1.40% 10-K · filed 2013-02-26 | |||
| 2010-10-03 | 1.40% 10-Q · filed 2011-11-04 | 1.40% 10-Q · filed 2011-11-04 | ||
| 2010-07-04 | 1.40% 10-Q · filed 2011-08-10 | 1.40% 10-Q · filed 2011-08-10 | ||
| 2010-01-03 | 1.90% 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |